Correlation Between Greenwich Lifesciences and Candel Therapeutics
Can any of the company-specific risk be diversified away by investing in both Greenwich Lifesciences and Candel Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Greenwich Lifesciences and Candel Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Greenwich Lifesciences and Candel Therapeutics, you can compare the effects of market volatilities on Greenwich Lifesciences and Candel Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Greenwich Lifesciences with a short position of Candel Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Greenwich Lifesciences and Candel Therapeutics.
Diversification Opportunities for Greenwich Lifesciences and Candel Therapeutics
0.55 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Greenwich and Candel is 0.55. Overlapping area represents the amount of risk that can be diversified away by holding Greenwich Lifesciences and Candel Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Candel Therapeutics and Greenwich Lifesciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Greenwich Lifesciences are associated (or correlated) with Candel Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Candel Therapeutics has no effect on the direction of Greenwich Lifesciences i.e., Greenwich Lifesciences and Candel Therapeutics go up and down completely randomly.
Pair Corralation between Greenwich Lifesciences and Candel Therapeutics
Given the investment horizon of 90 days Greenwich Lifesciences is expected to generate 0.57 times more return on investment than Candel Therapeutics. However, Greenwich Lifesciences is 1.76 times less risky than Candel Therapeutics. It trades about 0.11 of its potential returns per unit of risk. Candel Therapeutics is currently generating about -0.06 per unit of risk. If you would invest 1,309 in Greenwich Lifesciences on September 4, 2024 and sell it today you would earn a total of 100.00 from holding Greenwich Lifesciences or generate 7.64% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Greenwich Lifesciences vs. Candel Therapeutics
Performance |
| Timeline |
| Greenwich Lifesciences |
| Candel Therapeutics |
Greenwich Lifesciences and Candel Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Greenwich Lifesciences and Candel Therapeutics
The main advantage of trading using opposite Greenwich Lifesciences and Candel Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Greenwich Lifesciences position performs unexpectedly, Candel Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Candel Therapeutics will offset losses from the drop in Candel Therapeutics' long position.| Greenwich Lifesciences vs. Candel Therapeutics | Greenwich Lifesciences vs. Cingulate Warrants | Greenwich Lifesciences vs. Unicycive Therapeutics | Greenwich Lifesciences vs. Cardio Diagnostics Holdings |
| Candel Therapeutics vs. Aerovate Therapeutics | Candel Therapeutics vs. Adagene | Candel Therapeutics vs. Acrivon Therapeutics, Common | Candel Therapeutics vs. Rezolute |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Complementary Tools
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |